Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Incurable Cancer Diseases”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Not applicableLooking for participantsNCT05695638
What this trial is testing

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

Who this might be right for
Solid Tumor, Unspecified, AdultHaematological Malignancy
Morten Ladekarl 3,000
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Large-scale testing (Phase 3)Study completedNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 479
Post-approval studies (Phase 4)WithdrawnNCT00510627
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Who this might be right for
Metastatic Liver CancerSecondary Liver CancerLiver Neoplasm
Boston Scientific Corporation
Testing effectiveness (Phase 2)Study completedNCT01252628
What this trial is testing

Phase 1 and 2 Study of PX-866 and Cetuximab

Who this might be right for
Incurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cascadian Therapeutics Inc. 178
Early research (Phase 1)Study completedNCT01843725
What this trial is testing

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers

Who this might be right for
Metastatic Colorectal CancersMetastatic Gastric CancersMetastatic Oesophageal Cancers+3 more
Jules Bordet Institute 37
Testing effectiveness (Phase 2)Ended earlyNCT00101075
What this trial is testing

Title XELOX FOR SALIVARY GLAND CANCERS

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 9
Early research (Phase 1)Study completedNCT00003556
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00045266
What this trial is testing

VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT00740571
What this trial is testing

Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer

Who this might be right for
CancerNeuralgia
Radboud University Medical Center 130
Testing effectiveness (Phase 2)Ended earlyNCT01808534
What this trial is testing

Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

Who this might be right for
Adult Central Nervous System Germ Cell TumorAdult TeratomaMalignant Extragonadal Germ Cell Tumor+7 more
Indiana University 5
Not applicableLooking for participantsNCT04343365
What this trial is testing

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Who this might be right for
Incurable Disease
H. Lee Moffitt Cancer Center and Research Institute 35
Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Not applicableEnded earlyNCT01902966
What this trial is testing

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207944
What this trial is testing

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Who this might be right for
IPMNIPMN, Pancreatic
Duke University 100
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Testing effectiveness (Phase 2)Looking for participantsNCT07521852
What this trial is testing

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
TaiRx, Inc. 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05320692
What this trial is testing

TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 423
Early research (Phase 1)UnknownNCT00002887
What this trial is testing

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Ottawa Regional Cancer Centre 30
Load More Results